Suprefact Nasal 0,1 mg nas. spray sol. met. pump
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Buserelin Acetate 0,105 mg/dose - Eq. Buserelin 0,1 mg/dose
Available from:
Sanofi Belgium SA-NV
ATC code:
L02AE01
INN (International Name):
Buserelin Acetate
Dosage:
0,1 mg
Pharmaceutical form:
Nasal spray, solution
Composition:
Buserelin Acetate 0.105 mg/dose
Administration route:
Nasal use
Therapeutic area:
Buserelin
Product summary:
CTI code: 131826-02 - Pack size: 4 x 100 doses (10 (10) - Commercialisation status: YES - FMD code: 03582910087427 - CNK code: 0895946 - Delivery mode: Medical prescription; CTI code: 131826-01 - Pack size: 100 doses (10 (10) - Commercialisation status: YES - FMD code: 03582910087410 - CNK code: 0432971 - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
1985-06-13
